Pre-eminence and persistence of immature natural killer cells in acute myeloid leukemia patients in first complete remission

American Journal of Hematology

Volumn 86, Issue 2, 2011, Pages 209-213

  Dauguet, Nicolas ^a,b   Récher, Christian ^c   Demur, Cécile ^c   Fournié, Jean Jacques ^a,b   Poupot, Mary ^a,b   Poupot, Rémy ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; INTERLEUKIN 2 RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DX27; MONOCLONAL ANTIBODY DX9; MONOCLONAL ANTIBODY EB6B; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; B LYMPHOCYTE; CANCER CHEMOTHERAPY; CANCER PATIENT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXICITY; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; HUMAN CELL; IMMATURE NATURAL KILLER CELL; IMMUNOCYTOTOXICITY; INNATE IMMUNITY; LETTER; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LYMPHOCYTE COUNT; MONOCYTE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

ANTIGENS, CD56; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; LEUKEMIA, MYELOID, ACUTE; LYMPHOCYTE COUNT; LYMPHOID PROGENITOR CELLS; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; RECEPTORS, KIR; RECEPTORS, NATURAL KILLER CELL; REMISSION INDUCTION;

EID: 78851472118     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21906     Document Type: Letter

References (13)

1. Passegué E, Jamieson CH, Ailles LE, Weissman IL. Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci USA 2003; 100( Suppl 1): 11842-11849.
2. Döhner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010; 115: 453-474.
3. Rey J, Veuillen C, Vey N, et al. Natural killer and gammadelta T cells in hematological malignancies: Enhancing the immune effectors. Trends Mol Med 2009; 15: 275-284.
4. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097-2100.
5. Velardi A, Ruggeri L, Mancusi A, et al. Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: A tool for immunotherapy of leukemia. Curr Opin Immunol 2009; 21: 525-530.
6. Nguyen S, Dhedin N, Vernant JP, et al. NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: Immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. Blood 2005; 105: 4135-4142.
7. Verheyden S, Demanet C. NK cell receptors and their ligands in leukemia. Leukemia 2008; 22: 249-257.
8. Fauriat C, Just-Landi S, Mallet F, et al. Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction. Blood 2007; 109: 323-330.
9. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001; 22: 633-640.
10. - NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J Immunol 2007; 178: 4947-4955.
11. Lanier LL. Up on the tightrope: Natural killer cell activation and inhibition. Nat Immunol 2008; 9: 495-502.
12. Pittari G, Fregni G, Roguet L, et al. Early evaluation of natural killer activity in post-transplant acute myeloid leukemia patients. Bone Marrow Transplant 2010; 45: 862-871.
13. Dulphy N, Haas P, Busson M, et al. An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation. J Immunol 2008; 181: 2227-2237.